REQUEST A DEMO
Total
USD $0.00
Search more companies

Avicenna Pharmaceuticals Inc Public Joint Stock Company (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Avicenna Pharmaceuticals Inc Public Joint Stock Company Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Avicenna is a manufacturer of the solid dosage form of drug products. Founded in 2001, the company supplies various oral drug products to domestic and international clients. Business Development, Regulatory Affairs, Sales, Marketing and other administrative and financial functions are conducted through its head office in Tehran. Manufacturing and material management Departments are located in Kaveh Industrial Park, 90 km south of Tehran

Headquarters
Yusefabad, Jahanara Ave, 23 Rd St., No. 8
Tehran; Tehran; Postal Code: 1438933741

Contact Details: Purchase the Avicenna Pharmaceuticals Inc Public Joint Stock Company report to view the information.

Website: http://www.avicenna.ir

Basic Information
Total Employees:
Purchase the Avicenna Pharmaceuticals Inc Public Joint Stock Company report to view the information.
Outstanding Shares:
Purchase the Avicenna Pharmaceuticals Inc Public Joint Stock Company report to view the information.
Financial Auditors:
Purchase the Avicenna Pharmaceuticals Inc Public Joint Stock Company report to view the information.
Incorporation Date:
January 15, 2026
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
35.9%
Purchase this report to view the information.
8.42%
Purchase this report to view the information.
8.36%
Purchase this report to view the information.
5%
Purchase this report to view the information.
3.14%
Subsidiaries
Arasto Pharmacy Company
Company Performance
Financial values in the chart are available after Avicenna Pharmaceuticals Inc Public Joint Stock Company report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
81.54%
Total operating revenue
81.54%
Operating profit (EBIT)
189.42%
EBITDA
195.23%
Net Profit (Loss) for the Period
251.51%
Total Assets
33.36%
Total Equity
37.14%
Operating Profit Margin (ROS)
10.99%
Net Profit Margin
10.03%
Return on Equity (ROE)
3.84%
Debt/Equity
-8.3%
Quick Ratio
0.26%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?